Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

DFMO may help control hair growth and treat cancer.

MVP treatment is effective and safe for recurrent breast cancer.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Scalp cooling can effectively reduce hair loss during chemotherapy, with modern methods improving comfort and accessibility.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chemotherapy reduces splenic melanin in mice.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.